scholarly journals Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

Thorax ◽  
1999 ◽  
Vol 54 (7) ◽  
pp. 581-586 ◽  
Author(s):  
J C Bestall ◽  
E A Paul ◽  
R Garrod ◽  
R Garnham ◽  
P W Jones ◽  
...  
2020 ◽  
Vol 1 (1) ◽  
pp. 1
Author(s):  
Nayla Sa’adah Alawiyah ◽  
Muhammad Fachri

Latar belakang: Penyakit Paru Obstruktif Kronik (PPOK) merupakan penyakit tidak menular yang menjadi salah satu masalah kesehatan di Indonesia diperkirakan terdapat 4,8 juta orang dengan prevalensi 56%. Tujuan: tujuan penelitian ini untuk mengetahui hubungan antara hitung jenis leukosit dengan derajat PPOK berdasarkan gejala klinis dan PPOK GOLD 2019 pada pasien PPOK stabil di Rumah Sakit Islam Jakarta Sukapura periode September 2018 – September 2019. Metode: studi ini merupakan penelitian kuantitatif dengan metode deskriptif analitik. Desain penelitian yang digunakan yaitu cross sectional. Teknik pengambilan sampel dalam penelitian ini yaitu teknik total sampling. Jumlah pasien PPOK stabil yang diteliti sebanyak 35 pasien. Penilaian gejala pada pasien PPOK menurut Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) 2019 dapat menggunakan kuesioner yang sudah divalidasi yaitu COPD Assesment Test/CAT dan Modified Medical Research Council/MMRC. Hasil: Hasil pemeriksaan hitung jenis leukosit terbanyak memiliki nilai eosinofil normal, nilai basofil normal, nilai neutrofil meningkat, nilai monosit normal, dan nilai limfosit normal. Kesimpulan: hasil penelitian menunjukkan kecenderungan peningkatan nilai leukosit pada setiap derajat PPOK, namun secara statistik tidak terdapat hubungan yang signifikan antara hitung jenis leukosit dengan derajat PPOK berdasarkan gejala klinis dan GOLD 2019 pada pasien PPOK stabil di RSIJ Sukapura.


2021 ◽  
Vol 34 (13) ◽  
Author(s):  
Soraia Ribeiro ◽  
Carlos Seiça Cardoso ◽  
Margarida Valério ◽  
João Machado ◽  
José Costa ◽  
...  

Introduction: The Modified British Medical Research Council Questionnaire is considered an adequate and simple measure of breathlessness in chronic obstructive pulmonary disease. It is widely used in clinical practice in Portugal, but it still lacks confirmatory evaluation for the Portuguese setting. The aim of this study was to perform a cultural adaptation and validation of the Modified British Medical Research Council Questionnaire so that its most suitable version can be made available to researchers and clinicians in Portugal.Material and Methods: We performed a cross-sectional descriptive study involving patients with chronic obstructive pulmonary disease aged 40 years or older. We applied the Modified British Medical Research Council Questionnaire and the previously validated Portuguese-language version of the clinical questionnaire for chronic obstructive pulmonary disease between January and June 2019. We determined the agreement between the two questionnaires with kappa agreement, with a 95% confidence interval, and we used Spearman correlation to find a correlation between two scores.Results: The study included 65 patients managed in a hospital pulmonology clinic (aged 68 ± 7 years; with predicted FEV1 of 49.86% ± 16.5%). The Modified British Medical Research Council scale correlated significantly with all the domains and the overall score of the clinical questionnaire for chronic obstructive pulmonary disease (0.46 < r < 0.68; p < 0.001). In bilingual patients, interclass correlation coefficient was 0.912 (p < 0.001).Discussion: Our study showed that the Portuguese-language version of the Modified British Medical Research Council Questionnaire is feasible and externally valid when compared with a traditional and previously validated instrument.Conclusion: The Portuguese version of the Modified British Medical Research Council Questionnaire is a valid instrument for measurement of breathlessness in chronic obstructive pulmonary disease.


2021 ◽  
pp. 1-8
Author(s):  
Gihoon Jung ◽  
Chanhee Park ◽  
Jongseok Hwang ◽  
Joshua (Sung) H. You ◽  
Chunghwi Yi ◽  
...  

BACKGROUND: While respiratory and core-postural stabilisation has recently gained a widespread acceptance to improve pulmonary function and dyspena, the therapeutic effects of and rationale underlying the use of respiratory and core-postural stabilisation in the management of patients with chronic obstructive pulmonary disease have not been investigated. OBJECTIVE: This study aimed to compare the effects of abdominal breathing and respiratory and core-postural stabilisation on diaphragmatic movement and pulmonary function. METHODS: Fourteen patients with moderate chronic obstructive pulmonary disease were randomly assigned to either the respiratory and core-postural stabilisation or abdominal breathing group. All patients underwent fluoroscopy-guided chest X-ray imaging and pulmonary function tests before and after the interventions; the modified Medical Research Council questionnaire was also administered before and after the interventions. Six sessions of either intervention were consistently provided. The obtained data were assessed using independent t-tests and Wilcoxon signed-rank test with a significance threshold of P< 0.05. RESULTS: Respiratory and core-postural stabilisation was more effective in increasing diaphragmatic movements than abdominal breathing (P< 0.05). Pulmonary function tests revealed more significant differences in the forced vital capacity (FVC(%)predicted) only after respiratory and core-postural stabilisation (P= 0.004). The Medical Research Council questionnaire score was significantly different within the Respiratory and core-postural stabilisation group (P= 0.014). CONCLUSIONS: Our novel results suggest that the effects of respiratory and core-postural stabilisation breathing on diaphragmatic movement and pulmonary function were superior to those of abdominal breathing in patients with chronic obstructive pulmonary disease.


2019 ◽  
Vol 10 ◽  
pp. 204062231988220 ◽  
Author(s):  
Abebaw Mengistu Yohannes ◽  
Sheila Dryden ◽  
Nicola Alexander Hanania

Background: We examined the responsiveness of the Manchester Chronic Obstructive Pulmonary Disease (COPD) Fatigue Scale (MCFS) in patients with COPD following 8 weeks of pulmonary rehabilitation (PR). Methods: Patients ( n = 273) with clinically stable COPD completed 8 weeks of outpatient multidisciplinary PR, comprising 2 h (1 h exercise and 1 h education) weekly. Anxiety, exercise capacity, quality of life, dyspnea, fatigue were measured pre- and post-PR, utilizing the Anxiety Inventory for Respiratory Disease (AIR), Incremental Shuttle Walk Test (ISWT), St. George’s Respiratory Questionnaire (SGRQ), and modified Medical Research Council (mMRC) scale and MCFS, respectively. Results: The mean (SD) age of participants was 72 (8) years, and 50% were women. Total MCFS score fell after PR mean (95% confidence interval) −4.89 (–7.90 to −3.79) as did domain scores: physical −1.89 (–2.33 to −1.46), cognition −1.37 (–1.65 to −1.09), and psychosocial −1.62 (–2.00 to −1.62). Total MCFS effect size (ES) was 0.55; and for domains, physical was 0.52, cognition was 0.59, and psychosocial was 0.51. The ES for AIR was 0.30, mMRC was 0.38, SGRQ was 0.66, and ISWT was 1.19. MCFS changes correlated with changes in both SGRQ ( p < 0.002) and AIR ( p < 0.004), but not ISWT ( p = 0.30) or mMRC ( p = 0.18). The AIR, SGRQ, mMRC, and ISWT all improved after PR (all, p < 0.001). Conclusion: The MCFS scale is a valid and responsive scale to measure fatigue in patients with COPD after pulmonary rehabilitation.


Sign in / Sign up

Export Citation Format

Share Document